Rockwell Medical (RMTI) Cash from Investing Activities (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Cash from Investing Activities came in at -$122000.0 in Q1 2026, down 12100.0% YoY from N/an in Q1 2025, and up 97.05% on a QoQ basis from -$4.1 million in Q4 2025.
Rockwell Medical (RMTI) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 17 years of Cash from Investing Activities data on file, last reported at -$122000.0 in Q1 2026.
- Quarterly Cash from Investing Activities fell 12100.0% year-over-year to -$122000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8.7 million (down 83.27% YoY) and the FY2025 annual result came in at -$8.5 million, down 75.59% from the prior year.
- Cash from Investing Activities climbed to -$122000.0 in Q1 2026, from -$4.1 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $9.1 million in Q1 2022 to a low of -$14.7 million in Q3 2022.
- A 5-year average of -$1.1 million and a median of -$103000.0 in 2025 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2024 — Cash from Investing Activities soared 2782.81% — and 2026, when it sank 12100.0%.
- Tracing RMTI's Cash from Investing Activities over 5 years: stood at $3.2 million in 2022, then plunged by 37.6% to $2.0 million in 2023, then slumped by 116.53% to -$332000.0 in 2024, then sank by 1144.28% to -$4.1 million in 2025, then surged by 97.05% to -$122000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$122000.0 (Q1 2026), -$4.1 million (Q4 2025), and -$4.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | -491.00 Mn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | -300.00 Mn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -550.24 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 87.50 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | -51.60 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | -135.40 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | -110.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Rockwell Medical | 29.77 Mn | 4.98 Mn | 3.24 Mn | -487,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -487,000.00 |
| Jun 30, 2026 | -487,000.00 |
| Mar 31, 2026 | -122,000.00 |
| Mar 31, 2026 | -122,000.00 |
| Dec 31, 2025 | -4.13 Mn |
| Dec 31, 2025 | -4.13 Mn |
| Sep 30, 2025 | -4.31 Mn |
| Sep 30, 2025 | -4.31 Mn |
| Jun 30, 2025 | -103,000.00 |
| Jun 30, 2025 | -103,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Dec 31, 2024 | -332,000.00 |
| Dec 31, 2024 | -332,000.00 |
| Sep 30, 2024 | -6.11 Mn |
| Sep 30, 2024 | -6.11 Mn |
| Jun 30, 2024 | 1.72 Mn |
| Jun 30, 2024 | 1.72 Mn |
| Mar 31, 2024 | -139,000.00 |
| Mar 31, 2024 | -139,000.00 |